Beta Bionics, Inc. (BBNX)
10.57
+0.56
(+5.59%)
USD |
NASDAQ |
May 06, 16:00
10.56
-0.01
(-0.09%)
Pre-Market: 20:00
Beta Bionics Free Cash Flow : -61.12M for March 31, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Abbott Laboratories | 7.378B |
| Insulet Corp. | 349.90M |
| Tandem Diabetes Care, Inc. | -29.67M |
| Accuray, Inc. | -10.71M |
| Plus Therapeutics, Inc. | -20.84M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -23.83M |
| Cash from Investing (Quarterly) | 21.84M |
| Cash from Financing (Quarterly) | 0.623M |
| Free Cash Flow Per Share (Quarterly) | -0.5673 |
| Free Cash Flow to Equity (Quarterly) | -24.82M |
| Free Cash Flow to Firm (Quarterly) | -25.21M |
| Free Cash Flow Yield | -13.16% |